ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ...

By Yahoo! Finance   |   1 month ago
ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ...

The $8-$10 million deal includes additional engineering work over 18 months, with revenue drawn weekly. Future partnerships will follow this cash-based structure. Collaboration with Vultr enhances AI programs, improving efficiency and margins. Divesting European operations will cut costs and align with growth objectives.

Read More

Did you find this insightful?